Gut ‘Primes’ Pathogenic T Cells Responsible for Neuroinflammation in Multiple Sclerosis
Peer-Reviewed Publication
Updates every hour. Last Updated: 28-Mar-2026 02:15 ET (28-Mar-2026 06:15 GMT/UTC)
Gut-derived signals have been implicated in autoimmune inflammation, yet the underlying cellular mechanisms remain poorly understood. A recent study from Japan identifies a conserved gut–central nervous system axis through which gut signals contribute to autoimmune neuroinflammation. These findings suggest that targeting T cell activation in the gut may offer a strategy for limiting neuroinflammation in debilitating diseases like multiple sclerosis.
Dynamic switching between revival stem cells and conventional intestinal stem cells enables efficient tissue repair without exhausting the stem cell pool, report researchers from Institute of Science Tokyo. Using organoid and mouse disease models, the researchers uncovered how flexible stress-tolerant cell states contribute to intestinal repair—providing a better understanding of the biological mechanisms driving intestinal regeneration.
Solid materials for carbon capture can help reduce greenhouse gas emissions, but many existing systems remain energy-intensive and costly, because releasing captured carbon dioxide (CO2) typically requires high temperatures. Recently, researchers from Japan developed three kinds of 'viciazites', a new type of carbon-based material with precisely positioned nitrogen-containing functional groups. Through tight molecular control, these materials can release captured CO2 at temperatures as low as 60 °C, paving the way for efficient carbon capture.
The dedicator of cytokinesis 10 (DOCK10) gene has been identified as a key driver of abnormal insulin secretion in insulinomas, as reported by researchers from Institute of Science Tokyo. Using surgical specimens and patient-derived organoids, the team performed comprehensive genetic and transcriptomic analyses, revealing that inhibiting a DOCK10-related pathway reduced excessive insulin release in cellular and animal models. These results pave the way for novel diagnostic biomarkers and treatment options for insulinomas.